Industry
Sebia Acquires Autoimmune and Infectious Diseases Diagnostic Company Zeus Scientific
Sebia (Lisses, France), a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, has acquired Zeus Scientific, Inc. (Branchburg, NJ, USA), an IVD company specialized in autoimmune and infectious diseases technologies. More...12 Oct 2022
MEDICA 2022 to Take a Look at New Digital Reality and Revolutionary Technologies
As one of the world's leading medical trade fairs, MEDICA (Düsseldorf, Germany) in Düsseldorf presents innovations every year for the entire healthcare workflow, for clinical and outpatients. One example is the MEDICA CONNECTED HEALTHCARE FORUM (in Hall 12), a special platform for young entrepreneurs. More...10 Oct 2022
Surge in Adoption of Next-Gen Non-Invasive DNA Tests for High-Risk Pregnancies to Drive NIPT Market
The global non-invasive prenatal testing (NIPT) market is projected to register a CAGR of 14.8% between 2022 and 2031 to reach USD 8.4 billion by the end of 2031, driven by an increase in the prevalence of Turners' syndrome and Down's syndrome among newborn babies, as well as a surge in the adoption of next-gen non-invasive DNA tests in high-risk pregnancies. More...07 Oct 2022
Roche Appoints North American Head Matt Sause as Next CEO of Diagnostics Division
Roche (Basel, Switzerland) has announced that Matt Sause, currently Head of Roche Diagnostics’ North America Region, will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023. More...06 Oct 2022
Prof. Tomris Ozben of Turkey Elected Next President of the IFCC
The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC, Milano, Italy) has announced the election of Prof. Tomris Ozben, representing the Turkish Biochemical Society (TBS), as its next President. More...04 Oct 2022
Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
The findings of a new study suggest that interest among health care professionals in point-of-care technologies (POCTs) increased during the pandemic, with perceived applications of easy-to-use at-home, mobile or bedside devices in a broader range of diseases. More...29 Sep 2022
Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
Researchers have suggested that a system of reservist lab scientists should to be set up now to provide surge capacity that will help respond faster – and more effectively – to future outbreaks of infectious disease. More...29 Sep 2022
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
In Other News
Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology
Mindray Showcases Hematology Innovations at ISLH 2022
Pluslife and FIND Set Collaborate to Empower LMICs with Next-Gen POC Molecular Testing in Women’s Healthcare
AACC Releases Guidelines on Point-of-Care Testing for Non-Laboratorians
Global Diagnostic Labs Market Driven by Increased POCT Testing and Smart Portable Devices
Global PCR and Real-Time PCR Testing Market Driven by Need for Early Disease Detection
Medica Labmed Forum Presents Innovations from the World of Laboratory Medicine
Global Immunoassay Market Driven by Growing Incidence of Chronic and Infectious Diseases
Global Hematology Diagnostics Market Driven by Rising Prevalence of Blood Disorders
AACC Releases Updated Guidance to Improve Use of POC Tests for Fertility and Reproductive Health
Mindray Takes Home 288 IVDR CE Certificates to Cover All IVD Product Segments
Sectra Extends Medical Diagnostics Business to Include Genomics IT
Tianlong Holds Campaign for Children with Spinal Muscular Atrophy
Global Infectious Disease Diagnostics Market Driven by Evolving Pathogens and Increasing HAIs
Higher Efficacy of Blood Gas and Electrolyte Analyzers Driving Adoption in ICUs and Emergency Care
Buoyed by Rising Chronic Diseases, Global Clinical Diagnostics Market to Approach USD 100 Billion Mark by 2028
Global Viral Transport Medium Market Driven by Increasing Prevalence of Infectious Diseases
Microchip Imaging Cytometry Makes Laboratory Testing More Economical, Easy-To-Use and Accessible
DxGen and Precision Diabetes Partner to Launch New Diabetes POC Testing Analyzer in US
AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
BD and Accelerate Diagnostics Collaborate to Offer Rapid Antimicrobial Identification and Susceptibility Diagnostics
Bio-Rad Acquires Curiosity Diagnostics from Scope Fluidics
Global Sepsis Diagnostics Market Driven by Rising Demand for Assays and Reagents
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
